- RCEP: India in a Catch-22
- Humira’s Best-Selling Drug Formula: Start at a High Price. Go Higher.
- Cancer Drug Price Rises 1, 400% With No Generic to Challenge It
- UACT statement regarding Chilean Congress resolution calling on the President to advance the compulsory licensing request on HCV drugs
- Justice Prabha Sridevan on Life, Laughter and IP